Inhaled salbutamol for newborn breathing problems
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether an inhaled medication called salbutamol can help newborns with a temporary breathing condition called transient tachypnea of the newborn (TTN). It may help your baby breathe more easily and recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born after 35 weeks of pregnancy.
- Your baby must develop fast breathing or other signs of breathing trouble within the first 6 hours after birth.
- Your baby cannot have other serious lung or heart conditions, or certain birth defects.
- Your baby cannot have meconium aspiration syndrome or sepsis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an inhaled medication called tiotropium can help children who were born prematurely and have narrow airways. It may improve their breathing and lung function.
This study tests whether breathing in a salty mist helps babies with bronchiolitis recover faster than a plain water mist. It could ease breathing and reduce hospital stay.
This study compares two treatments for infants with bronchiolitis: a salty mist (3% hypertonic saline) and a breathing medicine (salbutamol). Both treatments help open airways, and the goal is to see which one works better to help your child breathe easier.
This trial tests whether giving inhaled salbutamol (a medication that opens airways) through a nebulizer can help people with pneumonia who are having trouble breathing and need oxygen support. It looks at how the treatment affects lung function and breathing effort.
This trial tests whether giving melatonin to full-term newborns with high blood pressure in their lungs (pulmonary hypertension) can help improve their breathing and oxygen levels. It may offer a new treatment option for babies with this condition.
This study looks at how children with bronchiolitis (a common lung infection in babies) respond to breathing treatments. It will also check if genes or other traits play a role. The goal is to better understand which treatments work best.
Hear when a new TTN trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.